NVCT
Nuvectis Pharma Inc
22.00$
+2.9%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | -100.0% | – | – | |
| – | – | +49.2% | +19.0% | – | – | |
| – | – | – | – | – | – | |
| – | – | +38.6% | +16.3% | -16.0% | +40.5% | |
| – | +13,854.2% | +79.4% | +25.1% | -7.8% | +36.0% | |
| – | +128,840.0% | +49.2% | +19.0% | -13.3% | +38.9% | |
| – | – | – | – | – | – | |
| – | – | +3,625.0% | – | – | – | |
| – | – | – | – | – | – | |
| – | – | – | – | -1,900,100.0% | – | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.